-
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Average Rating of "Buy" from Analysts
Source: Buzz FX / 23 Nov 2024 01:46:08 America/Chicago
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Average Rating of "Buy" from Analysts Written by MarketBeat November 23, 2024 Share Link copied to clipboard. Shares of EyePoint Pharmaceuticals, Inc.
Read more...